Lifecore Biomedical Board Changes Ahead of Annual Meeting
Company Announcements

Lifecore Biomedical Board Changes Ahead of Annual Meeting

Lifecore Biomedical ( (LFCR) ) has shared an announcement.

Lifecore Biomedical, Inc. is set to undergo changes in its Board of Directors as Jeffrey L. Edwards has chosen not to seek re-election and Ray Diradoorian plans to resign, both occurring around the company’s 2024 Annual Meeting scheduled for November 7. These decisions are not due to any operational disagreements. Shareholders interested in submitting proposals or nominations now face an October 3 deadline, following the regulatory and company bylaw requirements. These changes and submission details are crucial for investors as they could influence the company’s direction and governance.

See more insights into LFCR stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyLifecore to host virtual investor day on November 21
TheFlyLifecore appoints Guldager as vice president, operations
TheFlyLifecore reports Q1 EPS (53c) vs. (35c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App